Suchergebnisse - "Muller, Marcel A"

PubPharm (9)

1

Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron

enthalten in: Virology journal | 2023

von Schröder, S. | Richter, A. | Veith, T. | +9

2

Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron

enthalten in: Virology journal | 2023

von Schröder, S. | Richter, A. | Veith, T. | +9

3

In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs® 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2

enthalten in: Frontiers in pharmacology | 2023

von Emanuel, J. | Papies, J. | Galander, C. | +11

4

Corrigendum : Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells

enthalten in: Frontiers in pharmacology | 2021

von Papies, J. | Emanuel, J. | Heinemann, N. | +6

ErratumFor: Front Pharmacol. 2021 Oct 25;12:757666. - PMID 34759825

5

Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells

enthalten in: Frontiers in pharmacology | 2021

von Papies, J. | Emanuel, J. | Heinemann, N. | +6

ErratumIn: Front Pharmacol. 2021 Dec 17;12:814452. - PMID 34975509

6

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients

enthalten in: Emerging infectious diseases | 2020

von Okba, N. | Müller, M. | Li, W. | +16

CommentIn: Infect Control Hosp Epidemiol. 2021 May;42(5):638-639. - PMID 32530392

7

Nafamostat Mesylate Blocks Activation of SARS-CoV-2 : New Treatment Option for COVID-19

enthalten in: Antimicrobial agents and chemotherapy | 2020

von Hoffmann, M. | Schroeder, S. | Kleine-Weber, H. | +3

CommentOn: Cell. 2020 Apr 16;181(2):271-280.e8. - PMID 32142651

8

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

enthalten in: Cell | 2020

von Hoffmann, M. | Kleine-Weber, H. | Schroeder, S. | +10

CommentIn: Antimicrob Agents Chemother. 2020 May 21;64(6):. - PMID 32312781

9

Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses

enthalten in: Frontiers in immunology | 2020

von Schlickeiser, S. | Schwarz, T. | Steiner, S. | +15

1
[1]